These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24038392)

  • 81. Missense mutations outside the catalytic domain of the ABO glycosyltransferase can cause weak blood group A and B phenotypes.
    Seltsam A; Blasczyk R
    Transfusion; 2005 Oct; 45(10):1663-9. PubMed ID: 16181218
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Mutation-Structure-Function Relationship Based Integrated Strategy Reveals the Potential Impact of Deleterious Missense Mutations in Autophagy Related Proteins on Hepatocellular Carcinoma (HCC): A Comprehensive Informatics Approach.
    Awan FM; Obaid A; Ikram A; Janjua HA
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085066
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hyperphosphatemic Familial Tumoral Calcinosis With
    Dauchez A; Souffir C; Quartier P; Baujat G; Briot K; Roux C
    JBMR Plus; 2019 Jul; 3(7):e10185. PubMed ID: 31372591
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Identification of two novel mutations in the
    Sun L; Zhao L; Du L; Zhang P; Zhang M; Li M; Liu T; Ye L; Tao B; Zhao H; Liu J; Ding X
    Bone Res; 2016; 4():16038. PubMed ID: 27867679
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Hyperostosis with hyperphosphatemia: evidence of familial occurrence and association with tumoral calcinosis.
    Narchi H
    Pediatrics; 1997 May; 99(5):745-8. PubMed ID: 9113957
    [No Abstract]   [Full Text] [Related]  

  • 86. Assessing the relationship between the in silico predicted consequences of 97 missense mutations mapping to 68 genes related to lipid metabolism and their association with porcine fatness traits.
    González-Prendes R; Derks MFL; Groenen MAM; Quintanilla R; Amills M
    Genomics; 2023 Mar; 115(2):110589. PubMed ID: 36842749
    [TBL] [Abstract][Full Text] [Related]  

  • 87. In Silico-Based Structural Evaluation to Categorize the Pathogenicity of Mutations Identified in the RAD Class of Proteins.
    Anwaar A; Varma AK; Baruah R
    ACS Omega; 2023 Mar; 8(11):10266-10277. PubMed ID: 36969410
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hyperphosphatemia With Normal Kidney Function Associated With Genetic Variants of
    Schulz I; Kutscher A; Krall P; Carpio D; Ardiles L
    Kidney Int Rep; 2023 Dec; 8(12):2838-2841. PubMed ID: 38106599
    [No Abstract]   [Full Text] [Related]  

  • 89. miRNA-mediated GALNT modulation of invasion and immune suppression: A sweet deal for metastatic cells.
    Gaziel-Sovran A; Hernando E
    Oncoimmunology; 2012 Aug; 1(5):746-748. PubMed ID: 22934269
    [TBL] [Abstract][Full Text] [Related]  

  • 90. GALNT12 is not a major contributor of familial colorectal cancer type X.
    Seguí N; Pineda M; Navarro M; Lázaro C; Brunet J; Infante M; Durán M; Soto JL; Blanco I; Capellá G; Valle L
    Hum Mutat; 2014 Jan; 35(1):50-2. PubMed ID: 24115450
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Clinically Significant Missense Variants in Human GALNT3, GALNT8, GALNT12, and GALNT13 Genes: Intriguing In Silico Findings. Muhammad Ramzan M. Hussain, Jamal Nasir, Jumana Yousuf Al-Aama.
    J Cell Biochem; 2017 Oct; 118(10):3520. PubMed ID: 28792674
    [No Abstract]   [Full Text] [Related]  

  • 92. Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population.
    Monies D; Abouelhoda M; Assoum M; Moghrabi N; Rafiullah R; Almontashiri N; Alowain M; Alzaidan H; Alsayed M; Subhani S; Cupler E; Faden M; Alhashem A; Qari A; Chedrawi A; Aldhalaan H; Kurdi W; Khan S; Rahbeeni Z; Alotaibi M; Goljan E; Elbardisy H; ElKalioby M; Shah Z; Alruwaili H; Jaafar A; Albar R; Akilan A; Tayeb H; Tahir A; Fawzy M; Nasr M; Makki S; Alfaifi A; Akleh H; Yamani S; Bubshait D; Mahnashi M; Basha T; Alsagheir A; Abu Khaled M; Alsaleem K; Almugbel M; Badawi M; Bashiri F; Bohlega S; Sulaiman R; Tous E; Ahmed S; Algoufi T; Al-Mousa H; Alaki E; Alhumaidi S; Alghamdi H; Alghamdi M; Sahly A; Nahrir S; Al-Ahmari A; Alkuraya H; Almehaidib A; Abanemai M; Alsohaibaini F; Alsaud B; Arnaout R; Abdel-Salam GMH; Aldhekri H; AlKhater S; Alqadi K; Alsabban E; Alshareef T; Awartani K; Banjar H; Alsahan N; Abosoudah I; Alashwal A; Aldekhail W; Alhajjar S; Al-Mayouf S; Alsemari A; Alshuaibi W; Altala S; Altalhi A; Baz S; Hamad M; Abalkhail T; Alenazi B; Alkaff A; Almohareb F; Al Mutairi F; Alsaleh M; Alsonbul A; Alzelaye S; Bahzad S; Manee AB; Jarrad O; Meriki N; Albeirouti B; Alqasmi A; AlBalwi M; Makhseed N; Hassan S; Salih I; Salih MA; Shaheen M; Sermin S; Shahrukh S; Hashmi S; Shawli A; Tajuddin A; Tamim A; Alnahari A; Ghemlas I; Hussein M; Wali S; Murad H; Meyer BF; Alkuraya FS
    Am J Hum Genet; 2019 Jun; 104(6):1182-1201. PubMed ID: 31130284
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Evidence for GALNT12 as a moderate penetrance gene for colorectal cancer.
    Evans DR; Venkitachalam S; Revoredo L; Dohey AT; Clarke E; Pennell JJ; Powell AE; Quinn E; Ravi L; Gerken TA; Green JS; Woods MO; Guda K
    Hum Mutat; 2018 Aug; 39(8):1092-1101. PubMed ID: 29749045
    [TBL] [Abstract][Full Text] [Related]  

  • 94. New Pathogenic Germline Variants in Very Early Onset and Familial Colorectal Cancer Patients.
    Djursby M; Madsen MB; Frederiksen JH; Berchtold LA; Therkildsen C; Willemoe GL; Hasselby JP; Wikman F; Okkels H; Skytte AB; Nilbert M; Wadt K; Gerdes AM; van Overeem Hansen T
    Front Genet; 2020; 11():566266. PubMed ID: 33193653
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comprehensive Computational Analysis of Protein Phenotype Changes Due to Plausible Deleterious Variants of Human SPTLC1 Gene.
    Sadaf T; John P; Bhatti A
    Int J Mol Cell Med; 2019; 8(1):67-84. PubMed ID: 32195206
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Evaluation of GALNT16 polymorphisms to breast cancer risk in Chinese population.
    Wu H; He G; Song T; Zhang Y; Chen X; Chen H; Xiong W; Sun C; Zhao C; Chen Y
    Mol Genet Genomic Med; 2019 Aug; 7(8):e848. PubMed ID: 31286696
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Charge and Polarity Preferences for
    Manwar Hussain MR; Iqbal Z; Qazi WM; Hoessli DC
    Front Oncol; 2018; 8():29. PubMed ID: 29541627
    [TBL] [Abstract][Full Text] [Related]  

  • 98. N-acetylgalactosaminyltransferases in cancer.
    Hussain MR; Hoessli DC; Fang M
    Oncotarget; 2016 Aug; 7(33):54067-54081. PubMed ID: 27322213
    [TBL] [Abstract][Full Text] [Related]  

  • 99. BRAF gene: From human cancers to developmental syndromes.
    Hussain MR; Baig M; Mohamoud HS; Ulhaq Z; Hoessli DC; Khogeer GS; Al-Sayed RR; Al-Aama JY
    Saudi J Biol Sci; 2015 Jul; 22(4):359-73. PubMed ID: 26150740
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Colorectal cancer: A review of the genome-wide association studies in the kingdom of Saudi Arabia.
    Shaik AP; Shaik AS; Al-Sheikh YA
    Saudi J Gastroenterol; 2015; 21(3):123-8. PubMed ID: 26021770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.